Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

T1INTERNATIONAL USA

Filed by T1INTERNATIONAL USA.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 19, 2026
Income
Not reported
Expenses
Not reported
Filing UUID
7766ba25-ac2a-4887-8501-509f736b478a
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to the following bills: oS.1040: Drug Competition Enhancement Act oS.1041: Affordable Prescriptions for Patients Act oS.1095: Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act oS.1096: Preserve Access to Affordable Generics and Biosimilars Act oH.R.3160/S.1553: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act oH.R.3152/S.1546: Patent Eligibility Restoration (PERA) Act oH.R.3269: ETHIC Act

Literal federal measure citations: S.1553, S.1546

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.